When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PRNB - Sanofi BTK inhibitor successful in mid-stage MS study; shares up 3% premarket
Principia Biopharma Inc.
Sanofi (NASDAQ:SNY) perks up 3% premarket on light volume in reaction to positive results from a Phase 2b clinical trial evaluating SAR442168 in patients with relapsing multiple sclerosis (MS).
More news on: Sanofi, Principia Biopharma Inc., Healthcare stocks news, Stocks on the move,